WO2020240581A1 - Turmeric based aqueous dispersible formulations - Google Patents
Turmeric based aqueous dispersible formulations Download PDFInfo
- Publication number
- WO2020240581A1 WO2020240581A1 PCT/IN2020/050465 IN2020050465W WO2020240581A1 WO 2020240581 A1 WO2020240581 A1 WO 2020240581A1 IN 2020050465 W IN2020050465 W IN 2020050465W WO 2020240581 A1 WO2020240581 A1 WO 2020240581A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oil
- turmeric
- aqueous
- nanoformulation
- dispersible
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/43—Addition of dyes or pigments, e.g. in combination with optical brighteners using naturally occurring organic dyes or pigments, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
Definitions
- the invention relates to a formulation comprising an aqueous dispersible form of turmeric, its method of preparation and product thereof.
- the invention in particular relates to a turmeric nanoformulation product and a preparation method thereof.
- Curcuma sp. (a herbaceous perennial plant) or turmeric is a flowering plant from the ginger family, Zingiberaceae whose roots are extracted and the ground powder is used in most households in cooking as a main spice in curry.
- Wide varieties of turmeric are known to the civilization from centuries and are particularly used for flavoring, coloring and medicinal purposes.
- Turmeric contains a number of phytoconstituents with varying proportions based on the variety of the turmeric plant.
- the commonly used turmeric in Indian households comprises curcumin in the range of 1.5-3.0%, however some varieties of turmeric have even been reported to have upto 9% curcumin.
- curcuminoids chiefly, curcumins
- non-curcuminoids chiefly, turmerones
- curcumins have been used as antioxidants, antimicrobial, anti- inflamatory, anti-cancerous, for muscle regeneration, for wound healing etc., while turmerones have their own potential benefits like anti-diabetic, antioxidants, antibacterial, anti-inflamatory, anti-cancerous, anti-fungal etc.
- the present invention overcomes the drawbacks of the prior art and offers an improved way of utilizing the useful health benefits of turmeric.
- the present invention is envisioned to use the benefits of turmeric of which value addition has been done through nanotechnology interventions.
- the concept of ‘nano’ leads to enhanced dispersibility which is further correlated with enhanced bioavailability.
- Innumerable works have reported enhanced bio availability of phytoconstituents when encapsulated in nanoemulsions. This means that even low dosages will furnish therapeutic potential and turmeric is power packed with phytoconstituents. What have been focused on till now is curcumins only. The magic of turmerones is just beginning to unfold in the scientific fraternity, the sages already knew it, and that is the very basis of developing formulation of the present invention.
- a formulation comprising an aqueous dispersible form of turmeric and its method of preparation thereof.
- turmeric nanoformulation it provides for a turmeric nanoformulation, its method of its preparation and products derived thereof.
- an aqueous- dispersible turmeric nanoformulation comprising: an organic phase comprising turmeric powder, edible and co-emulsifiers comprising atleast of glyceryl mono stearate (GMS); an aqueous phase having emulsifiers comprising atleast of DK Ester F-160 added to 25.0% glycerol; wherein the organic phase and the aqueous phase are mixed in a ratio of 1 :5 (v/v) such that glyceryl mono stearate (GMS) and DK Ester F-160 are in ratio 0.6 - 2.0 to 1.6 - 5.0.
- GMS glyceryl mono stearate
- DK Ester F-160 are in ratio 0.6 - 2.0 to 1.6 - 5.0.
- the method for preparing an aqueous- dispersible turmeric nanoformulation comprises: preparing an oil phase by dissolving turmeric powder in edible oil; preparing an organic phase by mixing co emulsifiers comprising atleast of glyceryl mono stearate (GMS) with the oil phase; preparing an aqueous phase by adding emulsifiers comprising atleast of DK Ester F-160 to 25.0% glycerol in water; mixing the organic phase and the aqueous phase in a ratio of 1 :5 (v/v) and homogenizing the mixture to get the desired turmeric formulation. ; wherein the glyceryl mono stearate (GMS) and the DK Ester F-160 are in ratio
- the turmeric powder is dissolved in the edible oil is an amount ranging from 15% to 70% (w/v).
- the edible oil is selected from the group consisting of olive oil, sunflower oil, sesame oil, almond oil, corn oil, orange oil, lime oil, black pepper oil, nutmeg oil, basil oil, rosemary oil, clove oil, grapefruit oil, fennel oil, coriander oil, bergamot oil, cinnamon oil, lemon oil, peppermint oil, garlic oil, thyme oil, marjoram oil, lemongrass oil, ginger oil, cardamom oil, liquid paraffin, cotton seed oil, peanut oil, nut oil, soy oil, rapeseed oil, vitamin E oil, Vitamin E TPGS oil, fish oil, tallow- derived oil, silicone oil, castor oil, squalene oil, and/or their combinations thereof.
- the glyceryl mono stearate (GMS) is in the range of 0.6-2.0 gm.
- the DK Ester F-160 is in the range of 1.6-5.0 gm.
- the size of nanoparticles of the nanoemulsion formulation ranges from 160-300 nm.
- the nanoemulsion formulation has a shelf-life of atleast 6 months.
- the formulation exhibits good bioavailability, has improved stability, shelf-life, non-bitter taste and non-pungent smell.
- the formulation of the invention can be concocted with dairy products, including but not limited to milk.
- the dairy products of the turmeric formulation can be selected from, but not limited to, milk, buttermilk, yogurt, curd, and the other similar known diary products.
- the nano-formulation of the present invention get uniformly distributed across the liquid volume and lends a smooth physical appearance without any pungent taste.
- the turmeric shot formulation further comprises water-based flavours and extracts but not limited to clove, cinnamon, ginger, cardamom, other natural homemade flavours and artificial flavours particularly, spicy, masala flavours or the like.
- FIG. 1A - 1 B illustrate Mass Spectra profiles of Turmeric Oil and turmeric formulation in ES positive mode
- FIG. 2A illustrates Chromatogram of Turmeric Oil in LC-MS profiling
- FIG. 2B-2C illustrate mass spectrum of LC peaks of turmeric oil at different retention times
- FIG. 2D illustrates a Chromatogram of turmeric Formulation in LC-MS profiling
- FIG.2E illustrates a mass spectrum of LC peaks of turmeric formulation at different retention times
- FIG.3A illustrates a GC Chromatogram of turmeric oil
- FIG.3B-3C illustrate mass spectrum of GC peaks of turmeric oil at different retention times
- FIG.3D illustrates a GC Chromatogram of turmeric formulation
- FIG.3E, 3F, 3G, 3H illustrate mass spectrum of GC peaks of turmeric formulation at different retention times
- FIG.4A and 4B illustrate SEM and TEM micrographs of the nanoformulation respectively
- FIG.5A, 5B, 5C illustrate Size distribution profiles of the turmeric formulation
- FIG.5D illustrates a Zeta potential profile of the turmeric formulation
- FIG.5E - 5F illustrate Stability profile of TurO.1 and Tur0.05 variant respectively as depicted through zeta size measurements
- FIG.6A illustrates comparative analysis profiles of turmeric formulation with other two samples.
- FIG.6B illustrates sensory profile of TurMin variant 1 of the turmeric formulation.
- the invention described herein relates to a nano formulation comprising aqueous dispersible form of turmeric.
- the invention also relates to a method of preparation of the said formulation using a unique combination of emulsifiers.
- the unique combination of emulsifiers helps enhance the dispersibility and provides stability to the formulation.
- Turmeric is composed of volatile oil and curcuminoids that impart it aroma and antioxidant nature. Turmeric is also a very good source of omega-3 fatty acids and alfa-linolenic acid. Turmeric is known to possess its beneficiary effects of anti-inflamatory, anti-mutagenic, anti-cancer, antimicrobial and antioxidant activities to treat number of diseases and disorders.
- Turmeric has been widely accepted as an herbal medicine for the treatment of arthiritis, chronic anterior uveitis, conjunctivitis, skin cancer, small pox, chicken pox, wound healing, urinary tract infections, liver ailment, menstrual difficulties, dyspeptic conditions, gallbladder complaints, cancer, cardiovascular disease, Crohn’s disease, tropical pancreatitis, idiopathic orbital inflammatory pseudotumor, oral lichen planus, vitiligo, psoriasis, acute coronary syndrome, diabetes, lupus nephritis, renal conditions, acquired immunodeficiency syndrome, b-thalassemia, biliary dyskinesia, Dejerine-Sottas disease, cholecystitis, and chronic bacterial prostatitis.
- Curcumin has been identified as active ingredient of turmeric and is the widely studied nutraceutical (Sahdeo Prasad et al..Turmeric, the Golden Spice: From Traditional Medicine
- Emsifier and“Co-emulsifier” used herein refers to a chemical molecule with one hydrophilic and the other lipophilic end.
- the food grade emulsifiers are used to increase the stability and miscibility of hydrophobic and hydrophilic moiety.
- Emulsifiers and Co-emulsifiers include, but not limited to, glyceryl stearate, stearyl alcohol, cetyl alcohol, stearic acid dimethicone, a silicone (siloxane) surfactant, polysorbates, sodium laureth), phospholipids, for example lecithin, polyoxyethylene sorbitan mono- or tristearate, monolaurate, monopalmitate, mono- or trioleate, a mono- or diglyceride and other known food grade emulsifiers and/or their combinations thereof.
- the emulsifiers and co emulsifiers used in the present invention are selected from, but not limited to, DK Ester F- 160 and glyceryl mono-stearate.
- DK Ester F-160 refers to a known food grade emulsifier used majorly in the preparation of food products.
- DK Ester is a nonionic surface active agent and is an ester compound consisting of sucrose and fatty acids. The mixture corresponds to the varied nature of the emulsifier.
- DK Ester is sucrose esters of fatty acids also commonly referred to as sucrose esters or sugar esters are used for food application.
- DK Ester F-160 can be used as an emulsifying agent which is known to increase the solubility of food in water.
- Glyceryl monostearate refers to one of the widely used emulsifiers in the production of ice creams, margarine and spreads.
- the emulsifier is known to increase the water stable dispersion and improve heat shock resistance of the food items.
- Glyceryl monostearate works as a co emulsifier, aiding DK Ester F-160 as the emulsifier.
- the invention provides a unique solution for existing limitations with turmeric usage for example, challenges of dispersibility of turmeric in aqueous formats such as milk, buttermilk, and the likes. Also, the formulation of the present invention overcomes the existing drawback related to bitter taste of turmeric which usually limits its consumption to a large extent.
- the invention relates to a stable nano-formulation of turmeric, which is rich in phenolic components, which are well known as polyphenols.
- phenolic components which are well known as polyphenols.
- These polyphenols have antioxidant properties due to their radical scavenging activity or they act as free radical terminators.
- the antioxidants play a major role in human body but for a healthy body, there has to be a balance between antioxidants and pro-oxidants. Diversion of the ratio towards pro-oxidants leads to oxidative stress in the body. This oxidative stress can give rise to severe disorders like malignancies, cardiovascular disorders, diabetes, neurological disorders, renal diseases, aging, liver or respiratory disorders, skin diseases, inflammatory disorders etc.
- the formulation of the present invention provides for an anti-oxidant rich health supplement.
- the formulation can be used as nutraceutical food supplement as it provides upto 9.0% of curcumin along with non- curcuminoid components.
- turmeric has proven to be an effective nutritional supplement. Many studies show that it has major benefits for the body and brain. It offers tremendous anti-inflammatory properties as well. It helps the body to fight foreign invaders and also has a role in repairing damage. Turmeric has anti-inflammatory properties and has proven to helpful in a number of health conditions, including reduced pain in people with osteoarthritis and rheumatoid arthritis. It may also reduce cholesterol and triglyceride levels. Turmeric has also shown benefits and improved certain heart disease, cancer, metabolic syndrome, Alzheimer's and various degenerative conditions as well.
- Another embodiment of the invention relates to a stable nano-formulation of aqueous dispersible form of turmeric, which is used as an additive in dairy based foods such as milk, lassi, yoghurt, and the other similar known dairy products, in-order to develop functional foods.
- the commercial value of the product of the present invention is immense and long-term.
- the present invention provides a nutraceutical formulation that can be used with all known turmeric varieties. Also, under the FSSAI- Food Safety and Standards Authority of India, the product according to present invention satisfies all criteria to be classified as a nutraceutical. After the characterization of the formulation, it is apparent that it contains substantial concentrations of curcuminoids and non-curcuminoids, along with a unique ratio of emulsifiers which makes it a stable health promoting composition of natural bioactives (curcuminoids and non-curcuminoids).
- the emulsifiers used according to exemplary the embodiments of the invention are DK Ester F-160 and glyceryl monostearate.
- the combination of emulsifiers used in the present invention also provides uniform dispersion of the turmeric in aqueous formats such milk, buttermilk or the like.
- the invention provides a nutraceutical product formulation possessing health benefits of bioactive compounds present in the turmeric.
- the formulation of the present invention is an aqueous dispersible nanoformulation of turmeric with improved stability, shelf-life and non-bitter taste.
- the present invention provides a whole turmeric product.
- the whole turmeric consists two particular classes of phytoconstituents, the curcuminoids and non-curcuminoids.
- the curcuminoids mainly comprise curcumins, demethoxycucumins, bisdemothoxycurcumins and non-curcuminoids comprise turmerones, Ar-Turmerone, a-turmerone, eucalyptol etc.
- the curcuminoids and non- curcuminoids found in turmeric are responsible for healing properties and are of great therapeutic interest.
- the present invention overcomes the existing challenges of indispersibility of curcuminoids and non-curcuminoids found in turmeric and improves the same with Nanotechnology intervention.
- invention provides an aqueous-dispersible turmeric nanoemulsion formulation
- an organic phase comprising turmeric powder, edible oil and co-emulsifiers further comprising atleast of glyceryl mono stearate (GMS); an aqueous phase having emulsifiers comprising atleast of DK Ester F-160 added to 25.0% glycerol in water; wherein the organic phase and the aqueous phase are mixed in a ratio of 1 :5 (v/v) such that glyceryl mono stearate (GMS) and DK Ester F-160 are in ratio 0.6 - 2.0 to 1.6 - 5.0.
- GMS glyceryl mono stearate
- DK Ester F-160 are in ratio 0.6 - 2.0 to 1.6 - 5.0.
- the edible oil is selected from the group consisting of olive oil, sunflower oil, sesame oil, almond oil, corn oil, orange oil, lime oil, black pepper oil, nutmeg oil, basil oil, rosemary oil, clove oil, grapefruit oil, fennel oil, coriander oil, bergamot oil, cinnamon oil, lemon oil, peppermint oil, garlic oil, thyme oil, marjoram oil, lemongrass oil, ginger oil, cardamom oil, liquid paraffin, cotton seed oil, peanut oil, nut oil, soy oil, rapeseed oil, vitamin E oil, Vitamin E TPGS oil, fish oil, tallow- derived oil, silicone oil, castor oil, squalene oil, and/or their combinations thereof.
- the size of nanoparticles of the nanoemulsion of the inventive formulation ranges from 160-300 nm.
- the formulation of the invention has a shelf-life of atleast 6 months.
- invention provides an aqueous- dispersible turmeric nanoformulation comprising: an organic phase comprising turmeric powder, edible oil and co-emulsifiers further comprising atleast of glyceryl mono stearate (GMS); an aqueous phase having emulsifiers comprising atleast of DK Ester F-160 added to 25.0% glycerol in water; wherein the organic phase and the aqueous phase are mixed in a ratio of 1 :5 (v/v) such that glyceryl mono stearate (GMS) and DK Ester F-160 are in ratio 0.6 - 2.0 to 1 .6 - 5.0.
- GMS glyceryl mono stearate
- DK Ester F-160 are in ratio 0.6 - 2.0 to 1 .6 - 5.0.
- the turmeric powder is dissolved in edible oil is an amount in the range of 15% to 70% (w/v).
- the edible oil used in the invention is olive oil.
- the glyceryl mono stearate (GMS) ranges from 0.60-2.0 gm and DK Ester F-160 ranges from 1.6-5.0 gm.
- the glycerol in the aqueous phase can be mixed with an edible gum including, but not limited to hydroxyl propyl methyl cellulose, gum Arabic, xanthan gum and/or combinations thereof.
- invention provides a method for preparing an aqueous- dispersible turmeric nanoformulation, the method comprising: preparing an oil phase by dissolving turmeric powder in edible oil; preparing an organic phase by mixing co emulsifiers comprising atleast of glyceryl mono stearate (GMS) with the oil phase; preparing an aqueous phase by adding emulsifiers comprising atleast of DK Ester F-160 to 25.0% glycerol in water; mixing the organic phase and the aqueous phase in a ratio of 1 :5 (v/v) and homogenizing the mixture to get the desired turmeric nanoformulation; wherein the GMS and the DK Ester F-160 are in ratio of 0.6 - 2.0 to 1.6 - 5.
- GMS glyceryl mono stearate
- invention provides a method for preparing an aqueous- dispersible turmeric nanoformulation, the method comprising preparing an oil phase by dissolving turmeric powder in edible oil in the range of 15% to 70% (w/v); preparing an organic phase by adding 0.67-2.0 gm of glyceryl mono stearate (GMS) to 16.7 ml of oil phase at temperature of 58-62°C with continuous stirring between 350-400 rpm; preparing an aqueous phase by adding 1.67-5.0 gm DK Ester F-160 to 83.3ml of 25.0% glycerol in water and/or combinations of glycerol with edible gums at temperature between 30-40°C with continuous stirring between 600-800rpm;mixing the organic phase and the aqueous phase in a ratio of 1 :5 (v/v) with continuous stirring ⁇ 400 rpm at 35-38C to form the nanoemulsion, and homogenizing the said nanoemulsion to get the desired turmeric formulation.
- GMS glyce
- the glyceryl mono stearate (GMS) and DK Ester F-160 are in ratio of 0.67-2.0 to 1.67-5.0.
- a well-known concoction by adding turmeric (haldi) in warm milk, used particularly during (a) injuries, (b) joint pains (particularly, rheumatoid arthritis), (c) flu, (d) controlling sugar levels (for diabetics), and almost any ailment/discomfort in the body. And nowadays, for glowing skin as well.
- turmeric haldi
- haldi a well-known concoction, by adding turmeric (haldi) in warm milk, used particularly during (a) injuries, (b) joint pains (particularly, rheumatoid arthritis), (c) flu, (d) controlling sugar levels (for diabetics), and almost any ailment/discomfort in the body. And nowadays, for glowing skin as well.
- flavoured turmeric formulation comprising turmeric emulsions, sugar, milk, food grade emulsifiers, edible oil.
- the formulation further comprises additional food grade flavors selected from, but not limited to, kashmiri kesar or other natural identical flavoring substances; and additional permitted synthetic food colors selected from but not limited to E-102, E-1 10, E-122 or the like.
- the invention provides an unflavoured turmeric milk formulation (TurMil0.05 variant) which comprises low sugar content and low added flavours along with the other components of the turmeric milk formulation (TurMilO.1 variant) described in the previous embodiment. This unflavoured turmeric milk formulation is most suitable of elderly customers, diabetic patients and for the individual who likes low sugar and less artificial flavoring products.
- the dairy products of the turmeric formulation can be selected from, but not limited to, milk, buttermilk, yogurt, curd, and the other similar known dairy products.
- the nano-formulation of the present invention get uniformly distributed across the liquid volume and lends a smooth physical appearance without any pungent taste.
- the turmeric shot formulation further comprises water-based flavours and extracts but not limited to clove, cinnamon, ginger, cardamom, other natural homemade flavours and artificial flavours particularly, spicy, masala flavours or the like.
- the turmeric shot comprises food grade synthetic colors. These flavours and colors are used to enhance the flavour and make the product more consumable for a variety of consumers.
- the invention provides the method of making the turmeric formulation.
- the formulation of the invention can be concocted with dairy products, including but not limited to milk.
- Turmeric powder Turmeric powder, Olive Oil, Glycerol Monostearate, Glycerol, DK-ester F-160 [(Sucrose Fatty Acid Ester), deionized water.
- Turmeric infused olive oil hereafter referred to as turmeric oil
- turmeric oil is prepared by dissolving turmeric powder in olive oil (carrier) at 16.7% (w/v), under gentle stirring conditions maintained at 40°C for 6h, followed by holding under stationary conditions overnight (16h). The mixture is centrifuged at 5000rpm for 10 min between 25- 30°C, and the oil layer collected.
- Choice of the edible oil is based on triglyceride length and viscosity, important parameters for stability of formulations.
- Example 2 the same protocol was followed as that for turmeric nanoformulation in Example 1 , however instead of adding turmeric powder in olive oil (carrier) at 16.7% (w/v), 33.4% (w/v), 50.1 % (w/v) and 66.8 % (w/v) were added to yield higher content of turmeric in the formulation and they showed similar results.
- Turmeric powder Turmeric powder, Olive Oil, Glycerol Monostearate, Glycerol, DK-ester F-160 [(Sucrose Fatty Acid Ester), deionized water.
- Turmeric infused olive oil hereafter referred to as turmeric oil
- turmeric oil is prepared by dissolving turmeric powder in olive oil (carrier) at 16.7% (w/v), under gentle stirring conditions maintained at 40°C for 6h, followed by holding under stationary conditions overnight (16h). The mixture is centrifuged at 5000rpm for 10 min between 25- 30°C, and the oil layer collected.
- Choice of the edible oil is based on triglyceride length and viscosity, important parameters for stability of formulations.
- a ratio of 1 :5 (v/v) of Organic phase and Aqueous Phase is used to make the formulation.
- Example 6 the same protocol was followed as that for turmeric nanoformulation in Example 5, however instead of adding turmeric powder in olive oil (carrier) at 16.7% (w/v), 33.4% (w/v), 50.1 % (w/v) and 66.8 % (w/v) were added to yield higher content of turmeric in the formulation and they showed similar results.
- the formulation of the invention can be consumed as such in the form of turmeric shots to derive various health benefits of turmeric.
- Turmeric powder Turmeric powder, Olive Oil, Glycerol Monostearate, Glycerol, DK-ester F-160 [(Sucrose Fatty Acid Ester), deionized water.
- Two phases are prepared, Organic phase and Aqueous Phase, and thereafter mixed in the ratio 1 :5 as described for the making Example 1 .
- TurShot0.2 is a richer and creamier variant, with a fuller mouth feel.
- TurShot0.15 the third variant can be suitably derived from the above. A comparison of all the above variants is stated Table 1 below.
- Table 1 Illustrating the different components of TurShot Variants. Higher concentrations are prepared for specific variants and their sub variant can be developed, based on potency of turmeric in oil, in which case the addition of turmeric is done sequentially. This is because shots demand a higher potential.
- turmeric formulations which proves the use and presence of the turmeric as a whole (comprising curcuminoids and non-curcuminoids) in the invention, as opposed to using only curcumin.
- FIG. 1A and FIG. 1 B represent the values of the components of the turmeric found in both turmeric oil and turmeric formulation respectively.
- FIG. 2A shows the Chromatogram of Turmeric Oil.
- FIG. 2B-2C show the mass spectrum of LC peaks of turmeric oil at different retention times.
- the graph shown in FIG. 2D is the Chromatogram of Turmeric Formulation and
- FIG. 2E shows the Mass spectrum of LC peaks of turmeric formulation at different retention times
- turmeric oil As seen from the MS and LC-MS profiles of both turmeric oil, and turmeric formulation, there is presence of both classes of phytoconstituents in turmeric oil and the formulation (since the formulation is prepared using turmeric oil).
- Curcuminoids are non-volatile compounds, whereas turmerones are volatile.
- the aroma of turmeric is associated with turmerones.
- MS profiling indicated the presence of the compounds in the samples under study.
- LC-MS technique is used to ascertain the compounds and is used for non-volatile compounds. It is for this reason that in the LC-MS profiles shown in FIGS. 2A-2E, the abundance is of curcuminoids.
- FIG. 3A shows the GC Chromatogram of turmeric oil.
- FIG. 3B and 3C show mass spectrum of GC peaks of turmeric oil at different retention times.
- Table 2 below, enlists the identified compounds in turmeric oil during GC-MS profiling:
- FIG. 3D shows the GC Chromatogram of turmeric formulation.
- FIG. 3E - 3H show mass spectrum of GC peaks of turmeric formulation at different retention times.
- Table 3 below, enlists the identified compounds in the turmeric formulation during the GC- MS profiling:
- SEM Scanning Electron Microscopy
- TEM Transmission Electron Microscopy
- Three essential parameters of nanoformulations are Zeta-size, Pdl (Polydispersity index) and Zeta- potential.
- Bioengineering a formulation means achieving the desired size and controlling the size of the nanodroplets, whilst retaining the stability.
- a size between 150-200nm (nanometer) is desirable.
- Pdl depicts the uniformity of formulations.
- a Pdl below 0.45 confirms the monodisperse nature of the formulation and is desirable.
- Zeta potential is a measure of the surface charge on the nanodroplets.
- a potential higher than + 30mV (milliVolt) is desirable. All these parameters when studied over a period of several months depict the stability of the formulations.
- a typical size distribution profile is shown in the FIG.
- FIG. 5A-5C shows that of zeta potential.
- the Tur variants (turmeric formulation) have a stability of 6 months and more.
- the Tur0.2 variant is stable for one year.
- FIG. 5E and 5F show the Stability profile of TurO.1 and Tur0.05 variant respectively as depicted through zeta size measurements.
- FIG. 6A shows the comparative analysis profiles
- FIG. 6B shows the sensory profile of TurMin variant 1 for the criteria of appearance, taste, sweetness, taste etc.
- the present invention utilizes the therapeutic, health and wellness benefits offered by turmeric which value addition done through nanotechnology interventions.
- the variants of turmeric nanoformulation according to the various embodiments of the present invention are suitable for people from all walks of life. This can be consumed by for all including, but not limited to sportspersons, athletes, those with inflammatory conditions, and as an immunity enhancer by practically everyone.
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medical Informatics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN201911020742 | 2019-05-24 | ||
IN201911020742 | 2019-05-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2020240581A1 true WO2020240581A1 (en) | 2020-12-03 |
Family
ID=73553604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IN2020/050465 WO2020240581A1 (en) | 2019-05-24 | 2020-05-25 | Turmeric based aqueous dispersible formulations |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2020240581A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011036811A1 (en) * | 2009-09-28 | 2011-03-31 | 三栄源エフ・エフ・アイ株式会社 | Turmeric pigment composition and method for preparing same |
US20150232642A1 (en) * | 2014-02-18 | 2015-08-20 | Xerox Corporation | Polymeric nanoparticles comprising turmeric |
-
2020
- 2020-05-25 WO PCT/IN2020/050465 patent/WO2020240581A1/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011036811A1 (en) * | 2009-09-28 | 2011-03-31 | 三栄源エフ・エフ・アイ株式会社 | Turmeric pigment composition and method for preparing same |
US20150232642A1 (en) * | 2014-02-18 | 2015-08-20 | Xerox Corporation | Polymeric nanoparticles comprising turmeric |
Non-Patent Citations (1)
Title |
---|
HEE JOUNG JOUNG ET AL.: "Development of Food-Grade Curcumin Nanoemulsion and its Potential Application to Food Beverage System: Antioxidant Property and In Vitro Digestion", J FOOD SCI., vol. 81, no. 3, 25 January 2016 (2016-01-25), pages N745 - 53, XP055763168, DOI: 10.1111/1750-3841.13224 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xavier-Junior et al. | Microemulsion systems containing bioactive natural oils: an overview on the state of the art | |
KR100991675B1 (en) | Nanoemulsion and nanoparticle containing plant essential oil and method of production thereof | |
CN102811702B (en) | Liquid oral composition and method for producing same | |
WO2019023668A1 (en) | Cannabinoid composition having an optimized fatty acid excipient profile | |
Goik et al. | The properties and application of argan oil in cosmetology | |
Paul et al. | Essential oils: A review on their salient biological activities and major delivery strategies | |
JP5543651B1 (en) | Liquid composition containing useful components in turmeric and turmeric pigment | |
Abo-Atya et al. | Novel prospective of N. sativa essential oil analysis, culinary and medicinal uses | |
WO2018083677A1 (en) | Green approach in enhancing the bioavailability of oils, fats and other lipophilic bioactives and compositions thereof | |
Mostafa et al. | Nanoemulsions: a new approach for enhancing phytonutrient efficacy | |
US8852651B1 (en) | Plant extracts for use in enhancing immune system and brain modulation | |
WO2014148244A1 (en) | Oral composition | |
WO2020240581A1 (en) | Turmeric based aqueous dispersible formulations | |
JP2011523856A (en) | Combination of plant extract and PUFA | |
Srivastava et al. | Essential Oils | |
JP5543656B1 (en) | Composition containing useful ingredients in turmeric | |
AU2017322712B2 (en) | Odor masking formulations for natural compounds | |
KR20160134375A (en) | Water soluble composition comprising ginseng seed oil | |
JP2021127338A (en) | Composition containing lignan compound dissolved in essential oil | |
Kemkar et al. | 6-Shogaol rich ginger oleoresin loaded mixed micelles enhances in vitro cytotoxicity on mcf-7 cells and in vivo anticancer activity against dal cells | |
JP2021159083A (en) | Krill oil-containing composition | |
Chahande et al. | Herbal spices and nanotechnology for the benefit of human health | |
RU2779146C1 (en) | Flavored salad oil | |
Lim | Lavandula angustifolia | |
JP2009203179A (en) | Skin external preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20815034 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20815034 Country of ref document: EP Kind code of ref document: A1 |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20815034 Country of ref document: EP Kind code of ref document: A1 |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 31/10/2022) |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 20815034 Country of ref document: EP Kind code of ref document: A1 |